FIGURE 3.
Diagram of the numbers of patients with varices, splenomegaly, and portosystemic collateral vessels at the start of atezolizumab plus bevacizumab combination therapy.
Diagram of the numbers of patients with varices, splenomegaly, and portosystemic collateral vessels at the start of atezolizumab plus bevacizumab combination therapy.